-
Cesca Therapeutics Inc (NASDAQ: KOOL) shares
jumped 34.6 percent to $3.70 after a large insider buying was reported after the close on Wednesday.
-
Fortress Biotech Inc (NASDAQ: FBIO) shares
climbed 26.9 percent to $2.90 after the company disclosed that a patient case study from the Phase 1 clinical trial of MB-101
for the treatment of glioblastoma will be published in the New England Journal of Medicine.
-
Endologix, Inc. (NASDAQ: ELGX) shares rose 15.2
percent to $6.14 on the announcement the company has resumed shipments and procedures with its AFX and some sizes of its AFX2
products. Those products are used for the treatment of aortic disorders.
-
Prima BioMed Ltd (ADR) (NASDAQ: PBMD) shares
gained 14.8 percent to $2.64 following positive interim data from combination of IMP321 with anti-PD1.
-
Emergent Capital Inc (NYSE: EMG) rose 12.5 percent
to $1.26.
-
Endeavour Silver Corp (NYSE: EXK) shares gained 11.6
percent to $3.85. Endeavour Silver shares have jumped 146.43 percent over the past 52 weeks, while the S&P 500 index has
gained 8.25 percent in the same period.
-
Alamos Gold Inc (US) (NYSE: AGI) rose 10.4 percent
to $7.24. Gold futures gained 0.9 percent to trade at $1,150.90 an ounce.
-
Genius Brands International Inc (NASDAQ: GNUS)
surged 10 percent to $5.95. Genius Brands shares have climbed 56.81 percent over the past 52 weeks, while the S&P 500 index
has gained 8.25 percent in the same period.
-
Silver Wheaton Corp. (USA) (NYSE: SLW) gained 8.4
percent to $20.04. Silver futures rose 0.54 percent to $16.13 an ounce.
- Remark Media Inc (NASDAQ: MARK) shares climbed 7.2 percent to $4.03 after the company disclosed that it has been
chosen by Alibaba Cloud to introduce artificial intelligence-based technologies to the Chinese Market.
-
EnteroMedics Inc (NASDAQ: ETRM) gained 4.1
percent to $2.56 after falling 14.11 percent on Wednesday.
-
Sears Holdings Corp (NASDAQ: SHLD) shares rose
3.3 percent to $8.45. Sears reported up to $200 million line of credit.
© 2016 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.